Rein Therapeutics, Inc. (RNTX) — 10-K Filings
All 10-K filings from Rein Therapeutics, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Rein Therapeutics Files 2024 10-K, Cites Name Change & Financials
— Apr 7, 2025 Risk: medium
Rein Therapeutics, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly Aileron Therapeutics, Inc., is involved in pharmaceut -
Aileron Therapeutics, Inc. Files 2023 Annual Report on Form 10-K
— Apr 15, 2024 Risk: low
Aileron Therapeutics, Inc. (RNTX) filed a Annual Report (10-K) with the SEC on April 15, 2024. Aileron Therapeutics, Inc. filed its 2023 Form 10-K on April 15,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX